These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6751152)

  • 1. Preparation of nucleotide-free elongation factor Tu and its stabilization by the antibiotic kirromycin.
    Fasano O; Crechet JB; Parmeggiani A
    Anal Biochem; 1982 Jul; 124(1):53-8. PubMed ID: 6751152
    [No Abstract]   [Full Text] [Related]  

  • 2. The identification and analysis of nucleotides bound to the elongation factor Tu from Escherichia coli.
    Block W; Pingoud A
    Anal Biochem; 1981 Jun; 114(1):112-7. PubMed ID: 7197127
    [No Abstract]   [Full Text] [Related]  

  • 3. Molecular properties of two mutant species of the elongation factor Tu.
    Van der Meide PH; Duisterwinkel FJ; De Graaf JM; Kraal B; Bosch L; Douglass J; Blumenthal T
    Eur J Biochem; 1981 Jun; 117(1):1-6. PubMed ID: 7021152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 1H NMR study of the Escherichia coli elongation-factor Tu with guanine nucleotides and the antibiotic kirromycin.
    Römer R; Block W; Pingoud A; Wolf H
    FEBS Lett; 1981 Apr; 126(2):161-4. PubMed ID: 7016585
    [No Abstract]   [Full Text] [Related]  

  • 5. Preparation of Escherichia coli elongation factor Tu-guanosine 5'-triphosphate analogs.
    Delaria K; Jurnak F
    Anal Biochem; 1989 Feb; 177(1):188-93. PubMed ID: 2662816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-linking of tRNA at two different sites of the elongation factor Tu.
    Van Noort JM; Kraal B; Bosch L; La Cour TF; Nyborg J; Clark BF
    Proc Natl Acad Sci U S A; 1984 Jul; 81(13):3969-72. PubMed ID: 6377304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational transition of protein synthesis elongation factor Tu induced by guanine nucleotides. Modulation by kirromycin and elongation factor Ts.
    Douglass J; Blumenthal T
    J Biol Chem; 1979 Jun; 254(12):5383-7. PubMed ID: 447658
    [No Abstract]   [Full Text] [Related]  

  • 8. The elongation factor Tu . guanosine tetraphosphate complex.
    Pingoud A; Block W
    Eur J Biochem; 1981 Jun; 116(3):631-4. PubMed ID: 7021151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic analogs of aurodox and kirromycin active on elongation factor Tu from Escherichia coli.
    Chinali G
    J Antibiot (Tokyo); 1981 Aug; 34(8):1039-45. PubMed ID: 6119303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modification of elongation-factor-Tu . guanine-nucleotide interaction by kirromycin. A comparison with the effect of aminoacyl-tRNA and elongation factor Ts.
    Fasano O; Bruns W; Crechet JB; Sander G; Parmeggiani A
    Eur J Biochem; 1978 Sep; 89(2):557-65. PubMed ID: 251130
    [No Abstract]   [Full Text] [Related]  

  • 11. Structural features of the GDP binding site of elongation factor Tu from Escherichia coli as determined by x-ray diffraction.
    Rubin JR; Morikawa K; Nyborg J; la Cour TF; Clark BF; Miller DL
    FEBS Lett; 1981 Jun; 129(1):177-9. PubMed ID: 7023989
    [No Abstract]   [Full Text] [Related]  

  • 12. The antibiotics kirromycin and pulvomycin bind to different sites on the elongation factor Tu from Escherichia coli.
    Pingoud A; Block W; Urbanke C; Wolf H
    Eur J Biochem; 1982 Apr; 123(2):261-5. PubMed ID: 6122571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three dimensional structural elements of bacterial elongation factor Tu complexed with GDP.
    Clark BF; la Cour TF; Fontecilla-Camps J; Morikawa K; Nielsen KM; Nyborg J; Rubin JR
    Prog Clin Biol Res; 1982; 102 Pt C():59-64. PubMed ID: 6891962
    [No Abstract]   [Full Text] [Related]  

  • 14. The binding of kirromycin to elongation factor Tu. Structural alterations are responsible for the inhibitory action.
    Pingoud A; Urbanke C; Wolf H; Maass G
    Eur J Biochem; 1978 May; 86(1):153-7. PubMed ID: 350580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elongation factor Tu isolated from Escherichia coli mutants altered in TufA and tufB.
    Van der Meide PH; Borman TH; Van Kimmenade AM; Van de Putte P; Bosch L
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):3922-6. PubMed ID: 7001448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mutant elongation factor Tu which does not immobilize the ribosome upon binding of kirromycin.
    Duisterwinkel FJ; De Graaf JM; Schretlen PJ; Kraal B; Bosch L
    Eur J Biochem; 1981 Jun; 117(1):7-12. PubMed ID: 7021158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered regulation of the guanosine 5'-triphosphate activity in a kirromycin-resistant elongation factor Tu.
    Fasano O; Parmeggiani A
    Biochemistry; 1981 Mar; 20(5):1361-6. PubMed ID: 6112013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein synthesis elongation factor EFTu from Streptomyces collinus producing kirromycin.
    Mikulík K; Weiser J; Hasková D
    Biochem Biophys Res Commun; 1982 Sep; 108(2):861-7. PubMed ID: 6756407
    [No Abstract]   [Full Text] [Related]  

  • 19. Kirromycin drastically reduces the affinity of Escherichia coli elongation factor Tu for aminoacyl-tRNA.
    Abrahams JP; van Raaij MJ; Ott G; Kraal B; Bosch L
    Biochemistry; 1991 Jul; 30(27):6705-10. PubMed ID: 2065055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kirromycin, an inhibitor of protein biosynthesis that acts on elongation factor Tu.
    Wolf H; Chinali G; Parmeggiani A
    Proc Natl Acad Sci U S A; 1974 Dec; 71(12):4910-4. PubMed ID: 4373734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.